205 related articles for article (PubMed ID: 27565568)
1. Rapid LC-MS/MS method for the determination of 4-hydroxycholesterol/cholesterol ratio in serum as endogenous biomarker for CYP3A activity in human and foals.
Hasan M; Siegmund W; Oswald S
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1033-1034():193-199. PubMed ID: 27565568
[TBL] [Abstract][Full Text] [Related]
2. LC-ESI-MS/MS quantification of 4β-hydroxycholesterol and cholesterol in plasma samples of limited volume.
Xu Y; Yuan Y; Smith L; Edom R; Weng N; Mamidi R; Silva J; Evans DC; Lim HK
J Pharm Biomed Anal; 2013 Nov; 85():145-54. PubMed ID: 23948760
[TBL] [Abstract][Full Text] [Related]
3. Quantitation of P450 3A4 endogenous biomarker - 4β-hydroxycholesterol - in human plasma using LC/ESI-MS/MS.
Huang MQ; Lin W; Wang W; Zhang W; Lin ZJ; Weng N
Biomed Chromatogr; 2014 Jun; 28(6):794-801. PubMed ID: 24861746
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of 4β-Hydroxycholesterol and 25-Hydroxycholesterol as Endogenous Biomarkers of CYP3A4: Study with CYP3A-Humanized Mice.
Nitta SI; Hashimoto M; Kazuki Y; Takehara S; Suzuki H; Oshimura M; Akita H; Chiba K; Kobayashi K
AAPS J; 2018 Apr; 20(3):61. PubMed ID: 29858698
[TBL] [Abstract][Full Text] [Related]
5. 4β-Hydroxycholesterol as an endogenous biomarker of CYP3A activity in cynomolgus monkeys.
Li K; Zhao S; Zhang L; Wu X; Shu P; Wang Y; Feng H; Gu Z; Han Hsu H
Drug Metab Dispos; 2014 May; 42(5):839-43. PubMed ID: 24595680
[TBL] [Abstract][Full Text] [Related]
6. Use of 4β-hydroxycholesterol in animal and human plasma samples as a biomarker for CYP3A induction.
Xue YJ; Hoffmann M; Tong Z; Wu XI; Vallejo M; Melo B; Ye Y; Thomas M; Liu Y; Weiss D; Surapaneni S
Bioanalysis; 2016 Feb; 8(3):215-28. PubMed ID: 26805594
[TBL] [Abstract][Full Text] [Related]
7. A validated liquid chromatography-tandem mass spectrometry method for the quantitative determination of 4β-hydroxycholesterol in human plasma.
van de Merbel NC; Bronsema KJ; van Hout MW; Nilsson R; Sillén H
J Pharm Biomed Anal; 2011 Jul; 55(5):1089-95. PubMed ID: 21507593
[TBL] [Abstract][Full Text] [Related]
8. Sensitive UHPLC-MS/MS quantification method for 4β- and 4α-hydroxycholesterol in plasma for accurate CYP3A phenotyping.
Suzuki Y; Oda A; Negami J; Toyama D; Tanaka R; Ono H; Ando T; Shin T; Mimata H; Itoh H; Ohno K
J Lipid Res; 2022 Mar; 63(3):100184. PubMed ID: 35181316
[TBL] [Abstract][Full Text] [Related]
9. Recommendations on the Development of a Bioanalytical Assay for 4β-Hydroxycholesterol, an Emerging Endogenous Biomarker of CYP3A Activity.
Aubry AF; Dean B; Diczfalusy U; Goodenough A; Iffland A; McLeod J; Weng N; Yang Z
AAPS J; 2016 Sep; 18(5):1056-1066. PubMed ID: 27350147
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of 4β- and 4α‑hydroxycholesterol in human plasma and serum by UHPLC/ESI-HR-MS.
Hautajärvi H; Hukkanen J; Turpeinen M; Mattila S; Tolonen A
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Nov; 1100-1101():179-186. PubMed ID: 30340067
[TBL] [Abstract][Full Text] [Related]
11. Assessment of induced CYP3A activity in pregnant women using 4β-hydroxycholesterol: Cholesterol ratio as an appropriate metabolic marker.
Kim AH; Kim B; Rhee SJ; Lee Y; Park JS; Lee SM; Kim SM; Lee S; Yu KS; Jang IJ; Cho JY
Drug Metab Pharmacokinet; 2018 Jun; 33(3):173-178. PubMed ID: 29759884
[TBL] [Abstract][Full Text] [Related]
12. LC-MS/MS method for the determination of clodronate in human plasma.
Hasan M; Schumacher G; Seekamp A; Taedken T; Siegmund W; Oswald S
J Pharm Biomed Anal; 2014 Nov; 100():341-347. PubMed ID: 25194348
[TBL] [Abstract][Full Text] [Related]
13. A comparison of 4β-hydroxycholesterol : cholesterol and 6β-hydroxycortisol : cortisol as markers of CYP3A4 induction.
Mårde Arrhén Y; Nylén H; Lövgren-Sandblom A; Kanebratt KP; Wide K; Diczfalusy U
Br J Clin Pharmacol; 2013 Jun; 75(6):1536-40. PubMed ID: 23116409
[TBL] [Abstract][Full Text] [Related]
14. Quantification of 4-beta-hydroxycholesterol in human plasma using automated sample preparation and LC-ESI-MS/MS analysis.
Goodenough AK; Onorato JM; Ouyang Z; Chang S; Rodrigues AD; Kasichayanula S; Huang SP; Turley W; Burrell R; Bifano M; Jemal M; LaCreta F; Tymiak A; Wang-Iverson D
Chem Res Toxicol; 2011 Sep; 24(9):1575-85. PubMed ID: 21728364
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a LC-MS/MS method for the in vitro analysis of 1-hydroxymidazolam in human liver microsomes: application for determining CYP3A4 inhibition in complex matrix mixtures.
Mooiman KD; Maas-Bakker RF; Rosing H; Beijnen JH; Schellens JH; Meijerman I
Biomed Chromatogr; 2013 Sep; 27(9):1107-16. PubMed ID: 23674377
[TBL] [Abstract][Full Text] [Related]
16. 4β-Hydroxycholesterol as an Endogenous Biomarker for CYP3A Activity: Literature Review and Critical Evaluation.
Penzak SR; Rojas-Fernandez C
J Clin Pharmacol; 2019 May; 59(5):611-624. PubMed ID: 30748026
[TBL] [Abstract][Full Text] [Related]
17. Method development for the determination of 24S-hydroxycholesterol in human plasma without derivatization by high-performance liquid chromatography with tandem mass spectrometry in atmospheric pressure chemical ionization mode.
Sugimoto H; Kakehi M; Satomi Y; Kamiguchi H; Jinno F
J Sep Sci; 2015 Oct; 38(20):3516-24. PubMed ID: 26249017
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 3A activity in mothers and their neonates as determined by plasma 4β-hydroxycholesterol.
Nylén H; Sergel S; Forsberg L; Lindemalm S; Bertilsson L; Wide K; Diczfalusy U
Eur J Clin Pharmacol; 2011 Jul; 67(7):715-22. PubMed ID: 21246351
[TBL] [Abstract][Full Text] [Related]
19. Sex and CYP3A5 genotype influence total CYP3A activity: high CYP3A activity and a unique distribution of CYP3A5 variant alleles in Ethiopians.
Gebeyehu E; Engidawork E; Bijnsdorp A; Aminy A; Diczfalusy U; Aklillu E
Pharmacogenomics J; 2011 Apr; 11(2):130-7. PubMed ID: 20231858
[TBL] [Abstract][Full Text] [Related]
20. Fast LC-MS/MS analysis of free oxysterols derived from reactive oxygen species in human plasma and carotid plaque.
Helmschrodt C; Becker S; Schröter J; Hecht M; Aust G; Thiery J; Ceglarek U
Clin Chim Acta; 2013 Oct; 425():3-8. PubMed ID: 23827692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
